Skip to main content

Table 4 Independent correlates of highest modified Rodnan skin score recorded during follow-up, determined using linear regression

From: Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort

Variable a Parameter estimate Standard error P value
Anti-topoisomerase antibodies 4.37 0.98 < 0.0001
Anti-RNA polymerase III antibodies 7.67 1.09 < 0.0001
Joint contractures 8.47 0.81 < 0.0001
  1. aEver from disease onset (defined as date of onset of first systemic-sclerosis-related manifestation other than Raynaud's phenomenon) to most recent visit.